Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Dyskinesia, Drug-Induced

• Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients With Levodopa Induced Dyskinesia
• Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia
• Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy
• Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy
• Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components
• AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia
• Safinamide for Levodopa-induced Dyskinesia (PD-LID)
• Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
• Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
• Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia
• Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)
• Movement Disorders Caused by Antipsychotic Drugs in Older Patients
• Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia